| Affiliation: | 1. Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan;2. Shin Nippon Biomedical Laboratories (SNBL), Ltd., Tokyo, Japan;3. Shin Nippon Biomedical Laboratories (SNBL), Ltd., Kagoshima, Japan;4. SNBL USA, Ltd., Everett, WA, USA;5. Contractor to NCCT, Lockheed-Martin, Research Triangle Park, NC 27711, USA;6. National Center for Computational Toxicology (NCCT), U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA;1. Moores Cancer Center, University of California, San Diego, La Jolla, CA;2. Department of Biochemistry and Structural Biology, Celgene Corporation, San Diego, CA;1. Cardiovascular Biology and Biomechanics Laboratory, Cardiovascular Division, University of Nebraska Medical Center, Omaha, NE, USA;2. Chemical Engineering Department, University of Nebraska Lincoln, Lincoln, NE, USA;3. Cardiovascular Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA;1. Laboratorio de Hematobiología, Escuela Nacional de Medicina y Homeopatía (ENMH), Instituto Politécnico Nacional (IPN), Mexico City, Mexico;2. Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN (Cinvestav-IPN), Mexico City, Mexico;3. Department of Biomedical Science, University of Sheffield, Sheffield, UK;1. Vascular Biology Lab, AU-KBC Research Centre, Chennai, Tamil Nadu, India;2. Department of Biotechnology, Anna University, Chennai, Tamil Nadu, India;3. Ion Channel Biology Lab, AU-KBC Research Centre, Chennai, Tamil Nadu, India;4. SciGenom Labs, Cochin, Kerala, India |
